A new Diabetes Care publication from UFDI investigators explored how low-dose antithymocyte globulin (ATG) may help preserve insulin-producing cells in people with early type 1 diabetes in real-world clinical settings. The findings also highlight a simpler way to measure treatment response, which could help make future diabetes research and care more accessible.

Congratulations to authors David Weber, Joshua Modeste, Sarah Peeling, Timothy P. Foster, Brittany Bruggeman , Laura Jacobsen, Desmond A. Schatz, and Michael Haller on this important contribution to type 1 diabetes research.